BiotechTube
SONIRE Therapeutics

SONIRE Therapeutics

Tokyo, Japan· Est.

Developing a cavitation-enhanced, ultrasound-guided HIFU therapy system for minimally invasive treatment of intractable cancers, starting with pancreatic cancer.

sonire-therapeutics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

Developing a cavitation-enhanced, ultrasound-guided HIFU therapy system for minimally invasive treatment of intractable cancers, starting with pancreatic cancer.

Oncology

Technology Platform

A next-generation, cavitation-enhanced, ultrasound-guided High-Intensity Focused Ultrasound (HIFU) system designed to improve treatment speed and enable real-time visualization of the ablation zone.

Opportunities

Large unmet need in intractable cancers like pancreatic cancer, and the platform potential to expand HIFU treatment into new oncology indications beyond current urological and neurological uses.

Risk Factors

Technical risks in developing a novel, complex medical device; regulatory hurdles for a new class of therapeutic ultrasound; and future competition from established medtech companies in the image-guided therapy space.

Competitive Landscape

Competes in the therapeutic ultrasound segment against companies like Profound Medical and Insightec. Differentiation is based on cavitation-enhancement for faster treatment and improved visualization, specifically targeting deep-seated abdominal tumors.

More companies in Japan →